wire - news in brief
Pharmacology
Results 1 - 24 of 24.
Pharmacology - Health - 16.05.2024
Pharmacognosy brings nature to our medicine chests
Professor Mehdi Beniddir, both a researcher in chemistry and a pharmacist, explains how pharmacognosy makes it possible to develop new medicinal drugs from substances found in nature.
Pharmacology - Chemistry - 28.03.2024
Claire de March, a researcher with flair
Winner of the 2023 Irène Joliot-Curie Prize in the "Young Woman Scientist" category, this research chemist has developed the very first experimental structure of a human olfactory receptor.
Health - Pharmacology - 26.10.2023
Research DIRCOM ERC Synergy Grant 2023 for Immunotherapy of liver metastases
An international team of four distinguished immunologists, including Professor Eric Vivier of the Centre d'immunologie de Marseille-Luminy (CNRS/Inserm/AMU) has been awarded one of the most generously funded research grants from the EU: the ERC Synergy Grant. Leading in their respective fields of research, they aim to combine their expertise to explore new avenues for immunotherapy of liver metastases - a condition that affects approximately half of all cancer patients.
Health - Pharmacology - 04.08.2023
Omicron BA.1 virus infection in vaccinated patients remodels immune memory
Alberto Domingo Lopez-Munoz, Laboratory of Viral Diseases, NIAID/NIH Teams from the internal medicine department of the Henri-Mondor AP-HP hospital, the Institut Necker - Enfants Malades, the Mondor I
Health - Pharmacology - 21.04.2023
The CYTOBACT project was selected in the framework of the Carnot call for projects organized for the University Hospital Federations (UHF)
Health - Pharmacology - 14.04.2023
Covid: ’We have moved from an epidemic to an endemic situation’
The Covid epidemic has disappeared from the media in France, but not from the population. What is the situation in hospitals?
Health - Pharmacology - 20.03.2023
Does the Covid-19 vaccine have an adverse effect on menstrual cycles ?
According to a study led by CNRS researcher Alexandra Alvergne 1 , the Covid-19 vaccine does not cause advserse menstrual changes.
Health - Pharmacology - 23.02.2023
New data of efficacy of a Meningococcal B Vaccine and a Preventive Antibiotic in Reducing the Risk of Sexually Transmitted Bacterial Infections and proven efficacy of the MVA-BN Vaccine Against Mpox
Emerging Infectious Diseases in partnership with Roche , was conducted by a research team from the Paris Public Hospitals Group AP-HP, Université Paris Cité, Inserm, and Sorbonne Université in collaboration with the associations AIDES and Coalition PLUS.
Health - Pharmacology - 20.02.2023
Obesity and Overweight: Almost One in Two French People Affected. Current Situation, Prevention and Therapeutic Solutions
Photo i yunmai / Unsplash Obesity is a global public health problem whose incidence continues to increase.
Health - Pharmacology - 14.12.2022
Trial on safety and immunogenicity of Ebola vaccines yields promising results
Ebola epidemics occur periodically in various sub-Saharan African countries.
Health - Pharmacology - 09.12.2022
The Covid Crisis Has Made The Fight Against AIDS Invisible
With December 1 marking World AIDS Day , Professor Gilles Pialoux, head of the infectious diseases department at Tenon Hospital (AP-HP/Sorbonne University) and vice-president of the French Society fo
Pharmacology - Campus - 20.06.2022
The faculty of pharmacy of Marseille celebrates its 50th anniversary
Health - Pharmacology - 27.01.2022
Persistence of severe hepatic fibrosis despite substantial weight loss with bariatric surgery
A research team from AP-HP, Inserm and Sorbonne University carried out work, within the IHU ICAN, on the effects of bariatric surgery on the severity of liver damage in patients with NASH (Non-Alcoho
Pharmacology - Health - 18.01.2022
Covid-19: Who Should we Vaccinate First to Slow the Spread of New Variants?
Pharmacology - Innovation - 18.11.2021
GTP Nano leverages CEA’s NanO’up R&D facility to produce its first batches of drugs for precision therapies
Pharmacology - Social Sciences - 11.10.2021
Mamane Sani Souley Issoufou receives the French Red Cross Foundation Award
Health - Pharmacology - 20.07.2021
Impaired humoral and cellular immune responses to SARSCov-2 mRNA vaccine in virus unexposed patients receiving maintenance hemodialysis
The ROMANOV study found impaired humoral and cellular immune responses to SARSCov-2 mRNA vaccine in virus unexposed patients receiving maintenance hemodialysis The ROMANOV study found impaired humoral
Pharmacology - 22.03.2021
Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis patients
Publication of CIRI in Sciences advances on March 19, 2021. Toxic epidermal necrolysis (TEN) is a life-threatening cutaneous adverse drug reaction.
Pharmacology - 29.06.2020
New pharmaceuticals: public research combines efficiency with contained costs
Health - Pharmacology - 06.05.2020
Interferon-alpha deficiency in covid-19 patients: new therapeutic perspectives
Health - Pharmacology - 15.04.2020
Covid-19: CIRI mobilizes its teams to understand the immune response against Coronavirus in patients
A CIRI project, in collaboration with HCL, has united CIRI immunologists to work on understanding the immune response to Coronavirus in patients.
Pharmacology - 25.11.2019
Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants
Publication by CIRI on November 25, 2019. Dogma in transplantation holds that microvascular inflammation (MVI) triggered by recipient's antibody response against alloantigens (antibody-mediated rejection) is the main cause of graft failure.
Health - Pharmacology - 27.05.2019
Inhibitory checkpoint receptors control CD8+ resident memory T cells to prevent skin allergy
Publication by the International Center for Infectiology Research (CIRI) in The Journal of Allergy and Clinical Immunology on January 14, 2019.
Pharmacology - Life Sciences - 11.05.2018
Farnesoid X receptor-- is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo
Farnesoid X receptor- is a proviral host factor for hepatitis B virus that is inhibited by ligands in vitro and in vivo Abstract: Hepatitis B virus (HBV) infection and bile acid (BA) metabolism are in
Advert